In the present review, an attempt is made to crystallize, from the extensive and often contradictory literature on hypertension, a rational approach to the management of the hypertensive patient.
EVALUATION OF THE SIGNIFICANCE OF AN APPARENTLY HIGH BLOOD PRESSURE READING
There are several points which must be considered before a blood pressure reading can be classified as "normal" or "abnormal" for a given patient:
a. The method of measurement. Auscultatory methods for measuring blood pressure underestimate direct methods by increasing increments as the level of blood pressure rises.' Variations in the relation between the arm and sphygmomanometric cuff contribute further error to the determination as does the uncertainty as to which phase of the Korotkoff sounds is acceptable as the truest indication of the diastolic blood pressure. 8 101, 30 (Recent evidence favors use of the muffling of sounds rather than their disappearance.10") In addition, the position of the patient has a variable effect on the blood pressure which is of particular importance in patients under treatment with hypotensive drugs. Even without medication, the blood pressure of the standing patient may be as much as 25/10 mm.Hg lower than that of the same individual when supine.
b. The definition of "normal blood pressure." The limits of "normal" blood pressure remain ill-defined.2' On the one hand, upper limits of normal have been based on statistical averages of mixed groups which include unknown numbers of hypertensives.102 According to such data, more than 50%o of patients past the age of 50 years have blood pressures over 140/90. On the other hand, the value of about 140/90 has been set as the upper limit of normal on the basis of insurance groups from which higher values tend to have been pre-excluded.' Until better data, or more practical and safe methods of controlling blood pressure, are available, it may be best to consider values between 140/90 and the higher averages advocated by Master as "suspicious," but unproven hypertension.
c. Physiological variations of the blood pressure. The normal slight lability of the blood pressure is exaggerated in anxious patients so that diastolic as well as systolic hypertension may be present with excitement, or during initial blood pressure determinations, and may be absent in most subsequent measurements. Some of these "hyper-reacting" individuals may be more than usually likely to exhibit later hypertension.8263 In any event, many determinations of the blood pressure, under as restful conditions as possible, may be necessary in some patients to establish the usual range and average value of their blood pressure. Such data are best obtained as unobtrusively as possible in order to avoid overemphasizing the importance of the level and variations of blood pressure to the patient.
d. Diastolic vs. systolic values. Diastolic elevation of blood pressure, with which systolic elevation is usually associated, is of primary importance in relation to hypertensive vascular disease. An elevated systolic with normal or low diastolic value is not an indication of the more serious type of hypertension,* but may be associated with a variety of circumstances in which stroke volume or diastolic "run-off" is increased, or in which the elasticity or capacity of the large arteries is diminished. Systolic hypertension may be found with the high stroke volume of excitement, severe anemia, hyperthyroidism, bradycardia, marked peripheral vasodilatation, aortic insufficiency, and A-V shunts; or with aortic abnormalities such as coarctation, arteriosclerosis and obliterative endarteritis. (The latter process may, by involving the renal artery, cause more serious diastolic hypertension, as indicated below.) 11 . ETIOLOGICAL EVALUATION The finding of persistent diastolic hypertension imposes an obligation on the part of the physician to search, as briefly or as extensively as seems warranted in each instance, for one or more of the remediable etiological factors which may be involved in producing the hypertension. However, it is important to avoid overemphasizing to the patient, by an extensive investigation, the seriousness of an illness for which no truly remediable cause may be found and for which the available nonspecific therapy may well be unsatisfactory, or even unnecessary.
In general the more obviously serious the disease is, the more it warrants diligent search for a specific etiology, but at the same time it must be borne in mind that hypertension, due at first to a completely remediable primary cause (e.g., an ischemic kidney), may eventually become selfperpetuating even if the primary cause is removed. Early diagnosis of such a primary cause is therefore very important.
Diagram 1 illustrates the interplay of some of the physiological and pathological mechanisms which have been implicated in the production of hypertension. A detailed review of the experimental data upon which the diagram is based would be outside the scope of this presentation. The small numbers have therefore been included in order to indicate references which document the relations that are indicated in the diagram and summarized as follows:
a. The hemodynamic basis of hypertension is (with the exception of aortic coarctation) arteriolar obstruction to blood flow, caused by vasoconstriction and organic vascular disease (Diagram 1, No. 14), the cardiac output remaining normal. The question (see Diagram 1) of whether hypertension may, in itself, cause vascular disease is discussed in subsequent pages at length.
b. The renal vessels have been set aside from other peripheral vessels because of the experimental and clinical evidence indicating their particular importance to the problem of hypertension. e. The arterioles themselves may change in morphology or in reactivity to humoral pressor or neurogenic factors as a result of aging, heredity, or endocrine influences (Diagram 1, No. 9).
Many of the mechanisms outlined in the diagram are not susceptible to clinical evaluation. However, appropriate diagnostic procedures may be directed toward the following diseases which may give rise to hypertension:
1. Renal disease. Urinalysis, urine cultures, urine function tests (PSP, NPN, concentration test, inulin and PAH clearances), and the I-V pyelogram, correlated with the clinical history, will fairly well identify glomerular nephritis, pyelonephritis, and polycystic kidneys.' Although a good case can be made for a close relationship between pyelonephritis and associated hypertension,"2 convincing statistical evidence to the contrary has been presented."2' Antibiotic treatment of active pyelonephritis may prevent further renal damage but is quite unlikely to eliminate the associated hypertension. ' The finding of polycystic kidneys usually warrants some shift in emphasis from the problem of hypertension to that of gradually progressive renal 4. Toxemia of pregnancy is characterized by a rising diastolic blood pressure, increasing edema, and albuminuria in the young, previously normotensive, primigravid patient during the 7th-8th month of pregnancy.' In patients with pre-existent, persistent hypertension, indicated by history and by the presence of vascular changes in the fundi, toxemia tends to be more frequent (40-50%o) , earlier in occurrence (4th-5th month), and more severe." Many mild hypertensives do well during pregnancy, and appear to suffer no increase in their vascular disease. However, if progressive toxemia occurs for more than four to five weeks, subsequent persistent hypertension (in patients previously normotensive), or prolonged exacerbation of pre-existent hypertension is likely.""' Therefore, therapeutic abortion for severe hypertension during the first trimester, and intensive medical therapy, including salt restriction and the use of anti-hypertensive drugs (see Part III, below), for severe toxemia or eclampsia in the later months of pregnancy, are widely recommended." "2 88 5. Other unusual diseases which may be associated with hypertension are listed below. Their recognition will tend to shift the emphasis of prognosis and management from the hypertension to the primary disorder itself.
(a The problem of management in each case then involves repeated re-evaluation of the prospective morbidity and mortality of untreated as compared with treated disease.
The prognosis of untreated hypertension in each patient may be estimated, with only fair correctness, by a study of the initial characteristics of the disease and the course of associated vascular disease in the CNS, heart, and (especially) ocular fundi and kidneys. The results of the study can then be compared (grossly, or by an appropriate "scoring" system) with similar data reported for large series of cases in the literature."' 68' 495959587,95,108 The following initial characteristics favor the likelihood of a more benign course: age of patient more than 50, female sex, negative family history, relation to menopause, asymptomatic onset, prior duration for more than 10 years, diastolic values less than 120 mm.Hg, lability, absence of recent progression, absence of vascular disease. Specific evidence of lability may be given by spontaneous fall of the pressure to low or even normal levels when initial anxiety of the patient has been relieved, or during an amytal sedation test.
Data useful in estimating the extent of organic vascular disease may be outlined as follows:
1. Fundoscopic changes (see Part II, below). 2. Renal function-initial examination of the kidneys for the presence of disease has been described above in discussing primary renal disease. With respect to the problem of prognosis, an evaluation of the extent of renal impairment is also very important. Marked functional impairment usually indicates severe, progressive disease with a poor prognosis, and the possibility of a developing malignant phase. The PSP test (indicative of renal tubular function and blood flow), and the urine concentration test (indicative of more specific tubular functions) may indicate renal impairment long before it becomes evident via urinalysis or elevation of the NPN." Studies of the clearances of inulin and PAH, etc., may provide even earlier and more exact indications of the disproportionate reduction of renal blood flow (as compared with glomerular filtration) characteristic of severe hypertensive disease, but they are too burdensome to be applicable to the ordinary case of hypertension." " Percutaneous renal biopsy is potentially much more informative,.9 but has not yet been established as an entirely safe and truly valuable procedure for other than a few specially selected cases.
Evaluation and management of hypertension j GOODYER, ROSENTHAL, JAEGER 3. The heart. Left ventricular hypertrophy (as indicated by the electrocardiogram and chest film) is usually an indication of longstanding disease; congestive heart failure (often preceded by a diastolic apical gallop) and coronary disease (indicated by the electrocardiogram, and a history of angina or myocardial infarction) are particularly indicative of a serious prognosis. On the other hand, marked hypertension may persist for many years without these evidences of cardiac damage.
4. The CNS. A cerebral vascular accident in a hypertensive patient implies probable cerebral arterial or arteriolar disease and portends further cerebral vascular difficulties. Hypertensive encephalopathy, characterized by clouding of the sensorium or convulsions in the presence of extreme elevation of the blood pressure, usually indicates a very serious prognosis in the absence of a specific remediable cause for the hypertension. However, it is not necessarily associated with cerebral vascular disease, may have no neurological sequellae, and is therefore potentially completely reversible. Hypertensive encephalopathy in experimental animals is characterized by patchy increases in cerebral capillary permeability due to severe vasospasm.'" This pathogenesis seems more reasonable than the hypothesis that the elevated arterial pressure "breaks through" the arteriolar resistance to be transmitted to the post-arteriolar vascular bed.82 Encephalopathy may respond dramatically to antihypertensive drugs, particularly in the absence of uremia, probably by direct relief of vasospasm. The malignant phase of hypertension, in which encephalopathy is common, is of special import because it presages death within a year.'0 It is characterized by extreme diastolic hypertension, pathognomonic papilledema associated with severe retinopathy, and rapidly progressive renal and cardiac impairment.
A review of the above clinical data for a given hypertensive patient should, ideally, allow: (a) identification of the patient with one of several grades or groups of hypertensive disease for which the average prognosis is known; (b) comparison of this prognosis with that of the same grade of disease subjected to each of the available methods of therapy; (c) selection of that form of therapy which holds the most promise for improving the prognosis of the untreated disease.
In practice, only part of this complete evaluation can be made. Published data concerning prognosis of various groups of untreated and treated disease based primarily on fundoscopic findings (see Part II, below), as well as on "scoring" systems, are summarized in Table A . A representative "scoring" system, used in this clinic, is summarized in Table B . Each listed adverse, abnormal clinical finding is given a "severity index" from one to four depending on the degree or innate seriousness of the abnormality. The total "score" for the patient at any time in the course of his disease is derived by totalling the "severity indices." For purposes of reference to other data, four ranges of "scores" are compared with equivalent terms or numerical grades now in common use in the literature. The data of Tables A and B provide some gross statistical basis for "clinical judgment" concerning the choice of management for the individual patient (see Part III, below). However, the evident gaps and inadequacies of the data, and the The choice of treatment by "anti-hypertensive" agents also involves an evaluation of the validity of the implicit assumption that hypertension is itself productive of vascular disease. Against this assumption is the evident discrepancy between the degree of hypertension and the extent of the associated vascular disease. Patients with marked hypertension of unknown etiology, or due to aortic coarctation, may exhibit no evidence of vascular disease for many years,"7 whereas (but this is rare) the vascular disease of "malignant" hypertension may rapidly progress in spite of the return of the blood pressure to normal values.9" Furthermore, vascular lesions can be produced in animals by agents such as alylamine under conditions where primary hypertension is avoided."T However, there is increasing evidence which favors the view that hypertension may, in itself, cause arteriolar disease:
1. Renal biopsies indicate the absence of renal vascular disease during the early phases of essential hypertension."' 2. Neither pulmonary vascular disease nor pulmonary hypertension occur in essential hypertension9; pulmonary hypertension due to other causes is commonly attended by pulmonary vascular disease.'0 3. The vasculature of the unilateral Goldblatt kidney, which is protected from systemic arterial hypertension by the constricting clamp, escapes injury, whereas vascular disease is found in the "exposed" contralateral kidney.'0 Human case reports confirm this experimental observation."7 ' 4. Coarctation of the aorta, which causes initially remediable hypertension, may lead eventually to fixed hypertension (in 9 of 80 cases in one series'2), associated with vascular disease. ' 5. Hypertensive crises produced in dogs with sudden colloid infusions and with epinephrine cause severe arteriolar lesions resembling those of the malignant phase of essential hypertension.' 6. Unilateral renal disease, both in man and in the experimental animal, may cause hypertension which is ultimately associated with contralateral renal vascular disease.2"'0 7. Increasing evidence is accumulating of the amelioration or arrest of the course of vascular disease in some hypertensive patients by means of hypotensive agents which are not known to have primary effects on metabolism or the peripheral vasculature.
These observations, although not without objections (concerned with the possibility that an unrecognized primary "metabolic" abnormality may cause various mixtures of hypertension and arteriolar disease), justify the search for more effective and practical methods of blood pressure control. In addition, even the presently available measures are useful or may affect prognosis in ways which are not related to the prevention of vascular disease :
1. By providing an anxious patient (and his physician) with the reassurance that "something logical is being done," in a situation which may appear (sometimes for good reason) to portend serious disease.
2. By relief of distressing symptoms such as headache and irritability. 3 . By lightening the work load of the heart, particularly when failure is present or imminent, and relieving pulmonary engorgement in acute pulmonary edema. 4. By controlling hypertensive crises such as encephalopathy and eclampsia or pre-eclampsia.
These measures, with particular reference to drug therapy, are discussed in detail below (Part III).
PART II. EVALUATION OF FUNDOSCOPIC FINDINGS IN HYPERTENSION
The eye is the window in the human body where the vascular system at the arteriolar and precapillary level can be directly visualized. Much attention has therefore been paid to the vascular changes in the ocular fundus in hypertension, which when correlated with clinical and laboratory findings are of great importance in the estimation of prognosis. Photography, particularly stereophotography, of the fundus has been used in this clinic not only to evaluate the vascular changes present, but also to follow their development and course.
NORMAL ANATOMY OF THE RETINAL VASCULATURE Wagener and his associates"' have emphasized the importance of a thorough knowledge of the many variations of the normal eyegrounds. Friedenwald"' has clearly described the anatomical structure of the retinal vessels of various sizes and has classified the pathological changes which characterize each vessel type. The central artery, as it emerges from the optic disc, resembles arteries of similar size in many other organs. The intimal endothelial layer lies directly on the well-formed internal elastic lamella and the muscular coat is well developed. As the vessel passes forward, profound changes occur: the elastic lamella thins out and disappears after the first or second bifurcation, while the muscular coat is interrupted in increasingly wide gaps after a distance of about one disc diameter from the disc. With the exception of the retinal vessel near the disc, the visible vascular tree is arteriolar in character, the major branches of both arterioles and venules coursing at the level of the nerve-fiber layer. The precapillaries, however, can be divided into two groups: (i) the superficial group leading to capillaries in the nerve fiber layer; and (ii) the deep group leading to capillaries in the boundary plane between the inner nuclear and outer plexiform players. In general, the caliber of the retinal vessels narrows toward the periphery, most of the step-wise change being at the points of branching. The size of a branch is normally related to the size of its parent vessel in a ratio of 8: 10, or at most 7: 10. The choroidal circulation is made up of large vessels which lie near the sclera and a network of capillaries near the retinal border. At the equator of the choroid, there is a rich anastomosis between the anterior and posterior arterial groups. Ashton has shown1 that the choroidal circulation can be completely injected through a single anterior or posterior ciliary artery, even if one artery is severed before the injection. He suggested that localized lesions may occur in this circulation by leakage of blood or exudate with compression of adjacent choroidal vessels.
CLASSIFICATION OF FUNDOSCOPIC PATHOLOGY DUE TO HYPERTENSIVE DISESE
Several classifications are widely known and used, the more popular being that of Keith, Wagener, and Barker' in which the fundus changes are correlated with the clinical findings, or the classification of Wagener, Clay, and Gibnerm which limits itself to a very detailed description of retinal changes. Scheiel4u has recently outlined a very useful classification which emphasizes the differences between hypertensive (vasospastic) and arteriolosclerotic abnormalities, and which lends itself to reproducibility among several observers. Whatever method is used, certain vascular changes are recognized universally as being vasospastic and associated with hypertension per se:
1. Angiopathy-changes of the retinal vessels 2. Retinopathy-changes of the retina itself 3. Neuropathy-changes of the disc. 1. Angiopathy. In the early stages of hypertension the retinal arterioles may appear normal or even slightly dilated either because the retinal vessels share less in the generalized increase in arteriolar resistance which occurs, or because a change of the terminal arterioles cannot be appreciated ophthalmoscopically. In later phases of hypertension, irregularities (spasms) of the vessel walls are noted which may or may not be superimposed upon a more generalized narrowing. The latter is said to be characteristic of the occasional renal hypertension of elderly patients due to atherosclerosis of the renal arteries,TM'" and is said to correspond in degree with the severity of the hypertension in such individuals.
2. Retinopathy. In severe hypertensive disease, damage to the capillary wall and tissues of the retina results in extravasations and infarctions. Flame-shaped hemorrhages, localized exudates (of the "cotton-woll" variety), and edema so diffuse as to cause retinal detachments may be evident. In the macular region, the accumulation of fluid between the radially distributed Henle's fibers is the basis of the "macular star" (stellate figure) , which, however, is not pathognomonic of hypertension occurring in other pathological conditions. "Cotton-wool" patches about one-fifth the size of the disc may occur in the optic disc and in the region of the superficial capillary net, as a result, probably, of terminal arteriolar spasm.TM" On section, these disc-shaped spots reveal a thickened nerve-fiber layer which contains globular bodies called "cytoid bodies." 3. Neuropathy. When edema involves the optic nerve, it obliterates the margins of the disc and the physiological cup, and causes the nerve head to protrude. This finding is commonly associated with "hypertensive encephalopathy."
As a consequence of long-standing hypertension, morphological residua may become apparent. Hyaline material is deposited under the vascular endothelium as far as the capillary system. The separated muscle fibers appear as crescentic clumps and present the picture of hyaline swelling. When fulminant, the subendothelial swelling may be accompanied by necrosis of the endothelial layer. These changes of arteriolar sclerosis cause a different set of ophthalmoscopic findings than those described above as being manifestations of hypertension per se:
1. Changes of the arteriolar light reflex (c). "Silver wire" arterioles. The vessel wall is so dense that the blood column is obscured. The arteriole looks like a white cord.
2. Changes of the arterio-venous crossings. At these crossings, the arterioles and venules have a common anchorage because of a common adventitia. Normally, the venule passes undeviated closely over or under the arteriolar branch. As a result of arteriolar sclerosis the venule may be compressed as it crosses the arteriole, or may be deflected laterally so as to produce an abnormal, right-angle crossing, or an S-or U-shaped distortion. The vein may have the appearance of an arch or hump called a Salus' Sign if it passes in front of a sclerotic arteriole. The degree of compression is commonly graded I-IV. When Grade III, the venular column is partially obscured and appears tapered on each side of the crossing; when Grade IV, there is interference with the venous return and peripheral distention of the venule (Gunn's Sign, or "banking").
3. Vessel tortuosity. Loss of elasticity, thickening and lengthening cause increased tortuosity of both arterioles and venules.
4. Choroidal changes. These have been somewhat neglected in the literature concerning hypertension, probably because of their predominantly peripheral visualization in the fundoscopic examination. They are more often seen in the presence of severe hypertension, are ascribed to vascular sclerosis in the choroid, and are commonly associated with neuroretinopathy, though not necessarily so. In our experience, they have indicated a bad prognosis for the patient. They are evident as pigmentary changes visible in the choroid, through the peripheral retina, and are classified by Duke-Elder' as follows:
(a). Pale yellow or reddish plaques surrounded by pigmentary deposits. (b). Black, isolated flecks of pigment with bright red or yellow halos (Elschnig's spots).
(c). Chains of pigmented spots arranged like a string of beads along awhite, sclerosed vessel (Siegrist spots).
(
d). Large patches of chorioretinal atrophy.
The distinction between vasospastic and arteriolar sclerotic changes in the fundus, outlined in detail above, is carried out in the classification suggested by Scheie, given below. The vasospastic changes parallel, in general, the clinical severity of the hypertension, whereas the arteriolar sclerotic changes give an indication of the sequential morphological vessel damage associated with prolonged or severe hypertension. The former are more potentially reversible than the latter. Scheie Friedenwald' ' differentiated three other types of retinal vascular abnormalities potentially independent from one another and from the changes due to hypertension which have been described above.
1. The vascular changes of senescence. These should be differentiated from pathological, degenerative vascular disease, such as atherosclerosis which may not be inevitable. The fundoscopic picture of senescence is characterized by narrow, straight vessels with diminished light reflexes and a loss of retinal luster. Choroidal changes at the disc, in the macula, and in the periphery are common, being caused by fibrosis and hyalinization of the choroidal capillaries. 2. Atherosclerosis causes focal pathology usually not directly visible, having a predilection for the central retinal artery as it passes through the cribiform membrane. If the lumen is partially obstructed, the more peripheral arterial tree is narrowed. Occasionally, the actual atheroma may be observed at the disc, appearing as a local constriction or opaque spot in the vessel wall. If the lumen is occluded, a retinal infarct usually results, characterized by a segmental area of pale coagulation necrosis along the distribution of the occluded vessel. Central arterial thrombosis causes a cherry-red spot in the macula with surrounding pale necrosis. Because of the intimate association of artery and vein, intimal atherosclerosis may invade the vein, causing venous obstruction or thrombosis even though the artery remains patent. Widespread hemorrhagic retinal congestion and edema result. Fibrosis of an atheroma in the retinal artery may cause longitudinal shrinkage of the vessel, straightening the artery and narrowing its angle of bifurcation and/or drawing the retinal branches toward the disc.
3. Diabetic retinopathy. Recent studies by Ballantyne and Loewenstein,' and by Friedenwald' and Ashton' have shown that the typical lesion in diabetic retinopathy is the capillary aneurysm, affecting mostly the deeper capillary network, in contrast to the more superficial capillary involvement in hypertension. These microaneurysms appear as "punctate hemorrhages," in contrast to true hemorrhages which though occasionally punctate are usually more flame-shaped. They are almost specific for diabetes. True hemorrhages and waxy exudates may also be seen with diabetes, due to damaged capillaries. The extent of diabetic retinopathy is more clearly correlated with the duration of the disease than with its age of onset, severity, or the nature of its treatment.
PART III. MEDICAL TREATMENT OF HYPERTENSION
On the basis of the evaluations of etiology and prognosis discussed in Parts I and II, one or more of the various forms of therapy of hypertension may be applied. In some cases, treatment of the specific etiologic agent, or such simple measures as reassurance, weight reduction, or mild sedation, may be sufficient. However, in cases of more severe hypertension of unknown or unremediable origin, hypotensive medications may be indicated. Therefore, before presenting a general plan for the management of the various grades of hypertensive disease, it will be helpful to review the properties, side reactions, and clinical use of some of the newer hypotensive drugs. The pharmacological actions of these drugs are summarized in Table   TABLE C Table C ). The hypotensive, tranquilizing, and sedative properties of the Rauwolfia compounds are thought to be due, at least in large part, to their action at the level of the hypothalamus. Most patients observe a sense of well-being, improved sleep pattern, and decreased excitability and anxiety.
Toxicity and contraindications. The only serious untoward reaction reported so far has been a rare psychosis characterized by severe anxiety and depression. Other toxic effects are listed in Table D . Frequently, these side effects may be eliminated by reduction of dosage or by brief interruption of the drug.
Dosage and clinical use. The effects of Rauwolfia or its derivatives are gradual in onset and cumulative. The hypotensive effect may not become maximal until one to eight weeks after onset of therapy. These preparations are therefore given in daily doses (see Table D ) which are reduced when a therapeutic response is obtained.
Fixed, severe, or malignant hypertension seldom responds to Rauwolfia alone. LoefflerT' treated 51 severe or malignant hypertensives with this drug and observed prolonged reduction in blood pressure in only four patients.
Hensler," in treating a group of 60 hypertensives, observed no significant improvement in six cases of nephritis or in three cases of malignant nephrosclerosis. Hypotensive effects of Rauwolfia were observed in only 39%o of 218 patients treated by five different groups in America and Europe.l9""""5"' The Rauwolfia drugs, therefore, cannot be considered as highly effective hypotensive agents in themselves. Nevertheless, they are the drugs of choice in initiating hypotensive treatment, particularly because they often markedly decrease the severity of unpleasant side effects and the total dosage requirements of the more potent agents.
I. VERATRUM COMPOUNDS
Veratrum has been known to possess emetic properties since the early 1800's, its hypotensive effect in eclampsia having been recognized as early as 1860.8 There was little clinical use of this drug until 1949 at which time various purified extracts (see Table D ) were obtained which caused less disagreeable side effects than the crude preparation.
Pharmacological action (see also Table C ). The hypotensive effect of veratrum is thought to be mediated through the central nervous system by blockade of carotid and aortic receptors and by peripheral vasodilatation.'8"9 125 The drug has little or no primary sympatholytic or parasympathomimetic activity, and causes only minor changes in renal function. tolerance has not been reported. The most frequent side effects, listed in Table E , occur in close relation to therapeutic hypotensive activity. Consequently, the possibility of developing a potent hypotensive extract without unpleasant toxic effects remains remote. Efforts to alleviate these toxic symptoms by the use of atropine, belladonna, thorazine, dramamine, sedation, and Rauwolfia or its derivatives have not been successful. The veratrum preparations are best reserved for moderately severe and malignant hypertensives (see Diagram II), but are usually ineffective in patients with chronic severe uremia (NPN above 90 mg.%), or with severe cerebral arteriosclerosis.
Dosage and clinical use. The recommended dosage depends upon the specific preparation employed and usually varies from one to five tablets three times daily (see Chart I). Only 9 of 18 patients treated for 2-11 months in this clinic have been able to tolerate continued therapeutic doses of Vergytril or Protoveratrine. Statistically significant blood pressure reduction was observed in all 18 patients (see Diagram II), but toxic symptoms were frequent. Occasionally, left ventricular failure, retinopathy and headaches decreased, electrocardiographic abnormalities became less evident, and gallop rhythm, palpitations and angina subsided.
L-HYDRAZINOPHTHALAZINE
Hydralazine compounds characterized by a heterocyclic phthalazine ring and a hydrazine group have been shown to reduce blood pressure in experimental animals'1 and in human subjects.2' 67 79, 8 100, Of all the compounds tested, L-hydrazinophthalazine (Apresoline) has had the most extensive clinical trials and has the best effects on blood pressure with the least toxicity.
Pharmacological action (see Table C ). The hydralazines react with sulfhydryl radicals, carbonyl radicals, glucose and heavy metals, and are considered antienzymes, inhibiting amine oxidase, histaminase, and DOPA decarboxylase. In therapeutic dosage, they cause little or no peripheral adrenergic blockade (adrenolytic or sympatholytic) but increase cardiac rate and output, and inactivate certain humoral pressor substances such as pherentasin (said to be present in the blood of hypertensives, but not in normal blood).' The most powerful hypotensive action has been thought to be via suppression of sympathetic vasopressor impulses from the hypothalamus. However, recent evidence indicates a more important direct peripheral action causing dilatation of constricted vascular smooth muscle. In acute experiments, Apresoline increases renal blood flow, while glomerular filtration is unaffected. However, the renal function of patients with chronic severe renal damage is usually unimproved by the drug.' Toxicity and contraindications. When Apresoline is employed as the sole anti-hypertensive agent, side effects are frequent (see Table E ), the most serious being of cardiovascular origin. By augmenting the cardiac output and causing tachycardia, the drug may increase the coronary insufficiency of these patients with pre-existent coronary arteriosclerosis. ST-T segment depressions and T-wave changes closely resembling those of myocardial anoxia may be observed during the hypotensive response to Apresoline. Acute myocardial infarction has been described within 20 minutes of a dose of the drug.'0 The cardiac effects of the drug may also tend to increase congestive heart failure. Another serious toxic effect is the collagen disorder closely resembling acute lupus erythematosis-even to the finding of typical LE cells in the peripheral blood and bone marrow.92' " 10 Fortunately, this reaction, unlike true lupus, rapidly subsides when Apresoline is discontinued. Severe headaches may be very annoying during initiation of treatment, but usually subside as treatment is continued. Increased nervousness, nausea, and diarrhea are frequent, and, though not serious, may force discontinuance of therapy.
Dosage and clinical use. At the present time it is impossible to select in advance those patients who will respond to Apresoline. It has been suggested that neurogenic hypertension is more likely to respond than the hypertension associated with primary renal disease.1"5 The drug is better tolerated if given four times daily (after meals and at bed time). The usual initial dosage of 10 mg. q.i.d. is gradually increased to 50 mg. q.i.d. and then is further increased by increments of 50 mg. per dose until a satisfactory blood pressure response is observed, or until a total daily dose of 800 mg. has been reached. Dosages above 800 mg. usually increase the toxic effects without causing significant further reduction of the blood pressure. Treatment should be continued for at least five weeks before any lack of hypotensive effect is interpreted as a therapeutic failure. If a good response is obtained, the dosage should subsequently be reduced to the least amount consistent with a desired therapeutic or hypotensive effect.
Over a long period, tolerance to the drug commonly develops, as indicated by diminished side effects and less hypotensive response, in spite of gradually increasing dosage. n' Pharmacological action (see Table C ). Therapeutic dosage of either hexamethonium or Ansolysen causes the following: Toxicity and contraindications. Toxic effects of Ansolysen are similar to those of C6 (see Table E administration), it is thought to be 2-4 times more active on the sympathetic, and 1-2 times more active on the parasympathetic nervous systems. Oral administration may be safely begun in ambulatory patients with doses of 20-40 mg., a.c., q.i.d., and then increased by daily increments of 10-20 mg./dose until the desired hypotensive effects are obtained. Precautions similar to, but less strict than, those outlined for hexamethonium are advisable.
Parenteral administration is unnecessary for maintenance therapy but may be indicated for hypertensive emergencies. In such cases, the drug is given intravenously or subcutaneously in the same way as has been described above for C6, but in smaller doses, careful control of the semisitting blood pressure being required. The dosage is increased at 6-8 hour intervals in increments of 2 mg./dose, after an initial dose of 2 mg. Because of the potential hazards of any autonomic blocking agent, Ansolysen-even though more easily administered than hexamethonium-should also be reserved for patients with severe hypertension (see Table F ).
A. Hypertension in pregnancy. Toxemia of pregnancy may be defined as a disease characterized by hypertension, edema, and albuminuria which is peculiar to pregnancy, usually occurring during the third trimester (see Part I). Since its pathological physiology involves widespread arteriolar vasoconstriction and decreased blood flow to major organs such as the kidneys, uterus, and brain, therapy logically includes measures directed toward arteriolar dilatation. The ordinary sedatives are useful in this 8 regard, and intravenously administered magnesium sulfate (which has sedative as well as hypotensive actions) is useful in "pre-eclampsia" or "eclampsia." However, it seems logical to attempt to alleviate toxemic hypertension and its related symptoms with more purely hypotensive agents, in order to avoid deleterious depressant effects of oversedation on the infant, and in order to allow adequate clinical observation for other untoward (particularly cerebral) symptoms. For this purpose, the usefulness of the Veratrum compounds has been indicated in extensive clinical trials in which mortality from toxemia seems to have been reduced."32 Apresoline, which lowers the blood pressure and increases renal functions, cerebral blood flow, and cardiac output in toxemia,2 also appears to be a suitable agent for the treatment of this disease. The ganglionic blocking agents effectively reduce toxemic hypertension, but have the disadvantage of impairing renal flow and glomerular filtration, and cerebral blood flow. They have been used, therefore, chiefly in cases of toxemia superimposed on essential hypertension.
B. Hypertensive crises. Acute hypertensive crises, such as encephalopathy or acute pulmonary edema may be managed by cautious use of intravenous Veratrum or ganglionic blocking agents, administered in graded doses well diluted in a suitable vehicle such as saline or 5% glucose (see the discussions of each drug for further details). As indicated previously, lowering of the blood pressure in this way is more likely to relieve acute pulmonary edema, which usually tends to be functionally reversible, than to relieve encephalopathy, which is often the concomitant of fulminant vascular disease and/or uremia.
VI. THE USE OF THE HYPOTENSIVE DRUGS IN CONJUNCTION WITH LOW SODIUM

DIETS
The impressive work of Kempner has prompted extensive interest in the use of low sodium diets in the treatment of hypertension.' The effectiveness (30- congestive heart failure. Serious complications such as the development of the low sodium syndrome, renal failure, or severe metabolic acidosis, are unusual except in patients with marked renal impairment. However, side effects such as weight loss, weakness, and mental depression are frequent. In spite of the above disadvantages, the low sodium diet may be very useful in selected cases to potentiate the effects of the autonomic blocking agents if the latter have been partially or even completely ineffective.
VII. AN OVER-ALL PLAN FOR THE MEDICAL MANAGEMENT OF VARIOUS GRADES OF
HYPERTENSION
In the previous sections, the actions and uses of individual drugs have been discussed. In practice, it is usually desirable to combine one or more drugs with more general supportive measures in order to take advantage of complimentary hypotensive effects, while avoiding the side effects associated with the larger doses of each preparation. [14] [15] [16] [17] [18] [19] [20] , 36%o had moderate hypertension (scores 8-13), and 91% had mild hypertension (scores 1-7).
It would seem from our experience summarized in Diagram II that Apresoline, Veratrum, and the autonomic blocking agents have been useful in lowering the standing blood pressure of many patients. However, the ultimate long-term value of the use of such drugs, particularly with respect to the reversal or interruption of the course of organic vascular disease, remains to be proven.
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